Compositions and methods for Williams Syndrome (WS) therapy
US11730769B2 · kind B2 · utility
0Cited by
0References
8Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 21, 2018 |
| Grant date | Aug 22, 2023 |
| Priority date | — |
| Expiry date | Oct 28, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K45/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to compositions and methods for treating Williams syndrome (WS), herein identified as a neurodevelopmental oligodendrocyte hypomyelination-associated disease, and to compositions and methods for treatment of other neurodevelopmental myelination abnormality diseases or disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.